The EGFR R521K polymorphism influences the risk to develop colorectal cancer.
Martinelli M, Ugolini G, Scapoli L, Rivetti S, Lauriola M, Mattei G, Rosati G, Montroni I, Manaresi A, Zattoni D, Taffurelli M, Solmi R.
Martinelli M, et al. Among authors: manaresi a.
Cancer Biomark. 2010-2011;8(2):61-5. doi: 10.3233/DMA-2011-0826.
Cancer Biomark. 2010.
PMID: 21896992